Disclosure profile
Who’s trading AAL?
Open AAL on RobinhoodAmerican Airlines Group Inc. (AAL)
Every disclosed Congress and corporate-insider transaction in AAL (American Airlines Group Inc. (AAL)) — 36 trades from 19 politicians and executives, each AI-scored. Updated as new filings land.
Create a free account to open trades, see the full AI breakdown, and get live alerts when AAL is traded.
Create a free account →FilerActionAmountFiledScore
American Airlines Group Inc. (AAL)SEC 8-K——2026-06-166
KRONICK SUSAN DSEC Form 4——2026-06-123
HART MATTHEW JSEC Form 4——2026-06-125
KRONICK SUSAN DSEC Form 4——2026-06-123
CAHILL JOHN TSEC Form 4——2026-06-125
STEENLAND DOUGLAS MSEC Form 4——2026-06-124
Brown Adriane MSEC Form 4——2026-06-125
Dillon Mary NSEC Form 4——2026-06-125
Nesbitt Martin H.SEC Form 4——2026-06-124
Smith Gregory DSEC Form 4——2026-06-124
Ungerleider Howard ISEC Form 4——2026-06-124
Reynal VicenteSEC Form 4——2026-06-123
Farmer Kathryn MSEC Form 4——2026-06-124
American Airlines Group Inc. (AAL)SEC 8-K——2026-06-106
American Airlines Group Inc. (AAL) (CIK 0000006201)SEC 13GSell—2026-06-055
American Airlines Group Inc. (AAL)SEC 8-K——2026-05-297
Seymour DavidSEC Form 4——2026-05-046
Richmond Anthony J.SEC Form 4——2026-05-043
Owens AngelaSEC Form 4——2026-05-043
May Devon ESEC Form 4——2026-05-043
Hon. Lisa McClainHouse PTRBuy$1k2025-08-137
Hon. Tim MooreHouse PTRSell$50k2025-07-097
Hon. Tim MooreHouse PTRBuy$100k2025-07-098
Hon. Tim MooreHouse PTRSell$50k2025-07-097
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRBuy$15k2025-06-137
Hon. Tim MooreHouse PTRSell$250k2025-06-138
Hon. Tim MooreHouse PTRBuy$15k2025-04-147
Hon. Tim MooreHouse PTRSell$100k2025-04-148
Hon. Tim MooreHouse PTRBuy$15k2025-04-147
Hon. Tim MooreHouse PTRBuy$50k2025-04-148
Hon. Tim MooreHouse PTRBuy$50k2025-04-148
Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool — not investment advice.